Renal lymphangiectasia is a disorder of the lymphatic system of the kidneys, which can be congenital or acquired. Although the exact etiology remains unknown, an obstructive process resulting from several causes, including infection, inflammation or malignant infiltration, has been suggested to be responsible for the acquired form. This disorder may be associated with several pathologies. We report a case of a 24-year-old man with renal lymphangiectasia presenting with polycythemia, ascites and pleural effusion associated with hepatitis C virus (HCV) infection in an intravenous (IV) drug user. Our case is the first in the literature that shows an association between HCV infection and IV drug use.
INTRODUCTION
Renal lymphangiectasia is a rare benign etiology consisting of bilateral nephromegaly associated with perinephric and/or retroperitoneal fluid collection, ascites, and rarely, pleural effusion. It is also called renal lymphangiomatosis, renal lymphangioma, peripelvic lymphangiectasia and peripelvic multicystic lymphangiectasia. The preferred nomenclature is renal lymphangiectasia, which describes ectatic lymphatic vessels in renal parenchyma and perirenal and peripelvic regions (1) . The exact etiology remains unknown.
The neonatal form, essentially congenital, has also been described alongside the acquired type. It may be encountered at any age equally in men and women (2, 3) . A familial association has been reported in some cases (4) .
The most common hypothesis for the etiology of lymphoceles is the occlusion of draining lymphatic ducts secondary to trauma, scarring, infection, inflammation or malignant cells (4, 2) , all of which usually result in the events that lead to perinephric renal cyst formation and/or fluid collection around the kidneys. Progression during pregnancy has also been noted (1, 3) , and a total of 43 cases were reported between 1890 and 1993 (5 Three months later, 800 mL of pleural fluid was drained secondary to symptoms such as increased dyspnea ( Figure   1B ). 
